Curcumin and Nano-Curcumin for Diabetes Treatment in Rats
Author Information
Author(s): Hamed Amany M., Elbahy Dalia A., Ahmed Ahmed RH., Thabet Shymaa A., Refaei Rasha Abdeen, Ragab Islam, Elmahdy Safaa Mohammed, Osman Ahmed S., Abouelella Azza MA.
Primary Institution: Sohag University, Egypt
Hypothesis
This study aims to evaluate the effects of curcumin and its nanoformulation on insulin resistance and metabolic disorders in Wistar rats with dexamethasone-induced hyperglycemia and dyslipidemia.
Conclusion
Curcumin NPs are more effective than curcumin in reducing oxidative stress and improving metabolic parameters in diabetes.
Supporting Evidence
- Curcumin NPs showed greater improvements than curcumin in reducing oxidative stress.
- Body weight gain was significantly higher in the curcumin and curcumin NPs groups compared to the untreated diabetic group.
- Fasting blood sugar levels dropped by 35-40% in diabetic rats treated with curcumin and curcumin NPs.
- Levels of liver enzymes and cholesterol were reduced by 30-50% in treated groups.
- Curcumin NPs consistently showed superior effects compared to curcumin in improving metabolic health.
Takeaway
This study shows that a special form of curcumin, called nano-curcumin, helps lower blood sugar and improve health in diabetic rats better than regular curcumin.
Methodology
Thirty male Wistar rats were divided into five groups and treated with different substances for 14 days, with measurements taken for body weight and fasting blood sugar.
Potential Biases
The study was conducted on a homogeneous sample of male Wistar rats, which may not reflect the diversity of human populations.
Limitations
The study used a small sample size and short duration, which may limit the generalizability of the results.
Participant Demographics
Thirty male Wistar rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website